Gao Shan, Ni Xixiu, He Zhenxi, Wang Yanan, Sun Mingsheng, Liu Lu, Yu Yang, Liu Qing, Chen Xingyu, Wu Jianwei, Zhao Ling
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Clinical Research Center for Acupuncture and Moxibustion in Sichuan Province, Chengdu, China.
Evid Based Complement Alternat Med. 2021 Jun 21;2021:9932336. doi: 10.1155/2021/9932336. eCollection 2021.
. Chronic primary musculoskeletal pain (CPMP) is a major health problem that has physical and psychological impacts as well as an associated economic burden. Currently, pharmacological treatment remains unsatisfactory because of side effects and potential misuse. Therefore, nonpharmacological approaches for pain are being actively explored, and Tai Chi has attracted increased attention as a therapy for pain. Although clinical trials have shown that Tai Chi may be effective in treating CPMP, no systematic review has clarified its effectiveness and safety. The objective of this systematic review is to assess the effect and safety of Tai Chi for patients suffering from CPMP. . We will search relevant electronic databases from inception to May 31, 2021: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, the Wanfang database, the Chongqing VIP database, and China Biology Medicine Disc. Studies comparing the use of Tai Chi with other managements for CPMP patients will be included. Our review will include studies that measured change in pain intensity as the primary outcome using patient-reported ratings (visual analog scale or numerical rating scale). Hospital Anxiety and Depression Scale scores, SF-36 Health Survey scores, Pittsburgh Sleep Quality Index scores, and adverse effects will be explored as secondary outcomes. The risk of bias and the reporting quality of included studies will be evaluated using the Cochrane Collaboration risk-of-bias assessment method. The data will be analyzed using RevMan v5.3 software. . This study protocol was registered on PROSPERO. The registration number for this protocol is CRD42020165048.
慢性原发性肌肉骨骼疼痛(CPMP)是一个重大的健康问题,具有身体和心理影响以及相关的经济负担。目前,由于副作用和潜在的滥用,药物治疗仍然不能令人满意。因此,正在积极探索非药物疼痛治疗方法,太极拳作为一种疼痛治疗方法受到了越来越多的关注。尽管临床试验表明太极拳可能对治疗CPMP有效,但尚无系统评价阐明其有效性和安全性。本系统评价的目的是评估太极拳对CPMP患者的疗效和安全性。
我们将检索从起始到2021年5月31日的相关电子数据库:PubMed、EMBASE、Cochrane对照试验中央注册库、中国知网、万方数据库、重庆维普数据库和中国生物医学文献数据库。将纳入比较太极拳与其他CPMP患者管理方法使用情况的研究。我们的评价将包括那些以患者报告的评分(视觉模拟量表或数字评分量表)测量疼痛强度变化作为主要结局的研究。医院焦虑抑郁量表评分、SF-36健康调查评分、匹兹堡睡眠质量指数评分和不良反应将作为次要结局进行探讨。将使用Cochrane协作网偏倚风险评估方法评估纳入研究的偏倚风险和报告质量。数据将使用RevMan v5.3软件进行分析。
本研究方案已在PROSPERO上注册。该方案的注册号为CRD42020165048。